What if... We could harness the power of Flagship’s scientific platforms and create novel treatment options that benefit more patients, sooner?
Pioneering Medicines, an initiative of Flagship Pioneering, is building a world-class biopharmaceutical R&D capability focused on conceiving and developing life-changing treatments for patients by harnessing the power of Flagship's scientific platforms and applying those innovative approaches to serious diseases with unmet medical need. Unique to Pioneering Medicines’ approach is the opportunity to combine platforms to create truly novel and potentially transformative treatments.
About Flagship Pioneering:
Flagship Pioneering conceives, creates, resources, and develops first-in-category life science platform companies to transform human health and sustainability. Since its founding in 2000, the firm has originated and fostered the development of more than 100 scientific ventures, resulting in over $34 billion in aggregate value, 500+ issued patents, and more than 50 clinical trials for novel therapeutic agents.
Position Summary:
We are seeking a highly motivated and experienced Program Manager with Vaccines expertise at the Associate Director or Director level to join our team as a consultant.
This role will for 10-20 hours per week for 3-6 months.
Minimum Qualifications
- Experienced project manager with a Ph.D. or Masters degree
- 8+ years of experience in research and drug development.
- Proven experience in pharmaceutical drug development process across multiple phases of research
and development with timeline, management and budgetary responsibility - Background in vaccine development required with Flu vaccine experience a plus
- Highly adaptable, strong leadership skills and experience working in multi-company collaborations.
Key Responsibilities:
- Provide project management support for PM portfolio projects. Includes integrating into the team,
assuring progress toward plans, cross functional communication and identification of risks and
mitigation strategies - Support a project team from inception to approval of the project plan and budget. Working in
collaboration with the project lead, key activities include: - Form and coordinate a cross-company collaborative working team
- Identify key activities from the beginning of the project through DC/IND milestones.
- Definine key project decision points, team and company roles and responsibilities
- Build a budget to support the plan and seeking approval from senior management.
- Ensure communication both with leadership and across program partners and consultants.
- Ensure project plan is up to date in Smartsheet and monthly communication of project plan to leadership
- Support could be for 1 or more PM portfolio projects
Flagship Pioneering and our ecosystem companies are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.
Recruitment & Staffing Agencies: Flagship Pioneering and its affiliated Flagship Lab companies (collectively, “FSP”) do not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.
#LI-TD1
What We Do
Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability.
Since its launch in 2000, the firm has applied a unique, hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $30 billion in aggregate value. To date, Flagship is backed by >$3 billion of aggregate capital commitments, of which over $1.5 billion has been deployed toward the founding and growth of its pioneering companies alongside >$10 billion of follow-on investments from other institutions.
The current Flagship ecosystem includes Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO), Moderna Therapeutics (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Seres Therapeutics (NASDAQ: MCRB), and Syros Pharmaceuticals (NASDAQ: SYRS).
